Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|October 16, 2002
Expression of optineurin, a glaucoma-linked gene, is influenced by elevated intraocular pressureJason Vittitow, Teresa BorrásJournal of Cellular Physiology|July 29, 2004
Genes expressed in the human trabecular meshwork during pressure-induced homeostatic responseJason Vittitow, Teresa BorrásCurrent Therapeutic Research, Clinical and Experimental|June 30, 2023
In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye DiseaseJason Vittitow, Robert Kissling, Heleen DeCory, et al.Current Therapeutic Research, Clinical and Experimental|July 3, 2023
Oxygen-Carrying Capacity of Perfluorohexyloctane, a Novel Eye Drop for Dry Eye DiseaseNeal Stolowich, Jason Vittitow, Robert Kissling, et al.Ophthalmology|February 15, 2016
Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension: The APOLLO StudyRobert N Weinreb, Baldo Scassellati Sforzolini, Jason Vittitow, et al.Advances in Therapy|November 14, 2015
Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese SubjectsMakoto Araie, Baldo Scassellati Sforzolini, Jason Vittitow, et al.Cornea|January 8, 2025
In Vitro and In Vivo Visualization of Perfluorohexyloctane, an Eye Drop for Dry Eye Disease, Using Infrared EmissivityThomas James Millar, Jason Vittitow, Megan Cavet, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|October 28, 2009
Ocular surface distribution and pharmacokinetics of a novel ophthalmic 1% azithromycin formulationEsen Karamursel Akpek, Jason Vittitow, Rozemarijn S Verhoeven, et al.Pageof 1